ATR-dependent radiation-induced gamma H2AX foci in bystander primary human astrocytes and glioma cells.
Radiotherapy is an important treatment for patients suffering from high-grade malignant gliomas. Non-targeted (bystander) effects may influence these cells' response to radiation and the investigation of these effects may therefore provide new insights into mechanisms of radiosensitivity and responses to radiotherapy as well as define new targets for therapeutic approaches. Normal primary human astrocytes (NHA) and T98G glioma cells were irradiated with helium ions using the Gray Cancer Institute microbeam facility targeting individual cells. Irradiated NHA and T98G glioma cells generated signals that induced gammaH2AX foci in neighbouring non-targeted bystander cells up to 48 h after irradiation. gammaH2AX bystander foci were also observed in co-cultures targeting either NHA or T98G cells and in medium transfer experiments. Dimethyl sulphoxide, Filipin and anti-transforming growth factor (TGF)-beta 1 could suppress gammaH2AX foci in bystander cells, confirming that reactive oxygen species (ROS) and membrane-mediated signals are involved in the bystander signalling pathways. Also, TGF-beta 1 induced gammaH2AX in an ROS-dependent manner similar to bystander foci. ROS and membrane signalling-dependent differences in bystander foci induction between T98G glioma cells and normal human astrocytes have been observed. Inhibition of ataxia telangiectasia mutated (ATM) protein and DNA-PK could not suppress the induction of bystander gammaH2AX foci whereas the mutation of ATM- and rad3-related (ATR) abrogated bystander foci induction. Furthermore, ATR-dependent bystander foci induction was restricted to S-phase cells. These observations may provide additional therapeutic targets for the exploitation of the bystander effect.
Burdak-Rothkamm
S
S
Gray Cancer Institute, Mount Vernon Hospital, Northwood, UK. burdak-rothkamm@gci.ac.uk
Short
S C
SC
Folkard
M
M
Rothkamm
K
K
Prise
K M
KM
D001253:Astrocytes / Q000378:metabolism / Q000528:radiation effects*; D064007:Ataxia Telangiectasia Mutated Proteins; D024201:Bystander Effect / Q000528:radiation effects*; D018797:Cell Cycle Proteins / Q000235:genetics / Q000502:physiology* / Q000528:radiation effects; D002460:Cell Line; D045744:Cell Line, Tumor; D018920:Coculture Techniques; D005910:Glioma / Q000378:metabolism / Q000473:pathology / Q000532:radiotherapy*; D006657:Histones / Q000096:biosynthesis* / Q000528:radiation effects; D006801:Humans; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000502:physiology* / Q000528:radiation effects; D016196:S Phase / Q000235:genetics / Q000502:physiology / Q000528:radiation effects; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology* / Q000528:radiation effects
D018797:Cell Cycle Proteins; C468783:H2AX protein, human; D006657:Histones; C576597:ATR protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases